Streetbeat News

Equity Actions

MPWR

Monolithic Power Systems Inc. (NASDAQ:MPWR) stock dropped 1.31% to $583.00 in the current session, but increased by 0.52% over the past month and 50.72% over the past year. The company's P/E ratio is lower than the industry average, which could indicate it is undervalued or expected to underperform. Investors are advised to consider the P/E ratio alongside other financial metrics and qualitative analysis for investment decisions.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 6:15 pm

REGN

Regeneron Pharmaceuticals (NASDAQ:REGN) has been evaluated by 13 analysts over the last three months, with diverse opinions ranging from bullish to bearish. The average 12-month price target for REGN is $924.23, up 5.8% from the previous target of $873.57. Analysts from firms like Cantor Fitzgerald, Truist Securities, TD Cowen, Jefferies, Deutsche Bank, Piper Sandler, RBC Capital, Morgan Stanley, and Raymond James have provided updates, with some maintaining their ratings and others raising or lowering their price targets. Regeneron is known for its products in various medical fields and has shown strong financial health with a high net margin and ROE, a positive revenue trend, and a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 6:00 pm

OLN

Olin Corporation (NYSE:OLN) was analyzed by 11 analysts, showing diverse opinions. The average 12-month price target is $52.64, with a high of $66.00 and a low of $38.00, marking a 10.95% decrease in the average target. Analyst actions include both upgrades and downgrades, with ratings ranging from 'Overweight' to 'Underweight'. Olin's financials show a -28.01% revenue decline over 3 months, a high net margin of 6.23%, an ROE of 4.37%, an ROA of 1.32%, and a healthy debt-to-equity ratio of 1.34. The majority of Olin's revenue comes from the United States, with its largest segment being Chlor alkali products and Vinyls.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 6:00 pm

PJT

PJT Partners (NYSE:PJT) received mixed analyst ratings in the latest quarter, with 1 bullish, 2 indifferent, and 1 somewhat bearish rating. The 12-month price targets have an average of $99.0, with a high of $108.00 and a low of $89.00, reflecting a 2.41% increase from the previous average of $96.67. Analysts from UBS, Goldman Sachs, and Wolfe Research adjusted their ratings and price targets, indicating varied expectations for PJT's performance. PJT Partners is an advisory-focused investment bank with a majority of its revenue from the US, showing solid revenue growth, a high ROE, and an impressive ROA, but a net margin below industry benchmarks and a market capitalization smaller than industry averages.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 6:00 pm

SAP

SAP Inc. (NYSE:SAP) shares are trading at $152.32, with a 0.15% drop in the current session and a 3.75% decrease over the past month, despite a 32.61% increase over the past year. The company's P/E ratio of 76.2 is lower than the Software industry average of 148.83, which could suggest that SAP is undervalued or that shareholders expect less future growth. Investors are advised to consider the P/E ratio alongside other financial metrics and qualitative analysis.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 6:00 pm

SLB

On CNBC, Amy Raskin revealed that her firm has trimmed its position in Schlumberger N.V. (SLB). No specific reasons for the decision or details on the extent of the trimming were provided in the article.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 5:09 pm

NKE

Amy Raskin, on CNBC, has announced that her firm has trimmed its position in Nike, Inc. (NKE).

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 5:08 pm

UBER

On CNBC, Sarat Sethi revealed that he has reduced his investment in Uber Technologies, Inc. This could indicate a lack of confidence or a strategic portfolio adjustment.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 5:07 pm

CSCO

On CNBC, Sarat Sethi revealed that he has sold his position in Cisco Systems, Inc. This announcement could influence investor sentiment and potentially impact Cisco's stock price in the short term.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 5:06 pm

PFE

On CNBC, Josh Brown, a well-known financial analyst, announced that he has purchased shares of Pfizer, Inc. (PFE).

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 5:04 pm